The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review

The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review

Malignant pleural mesothelioma (MPM) is an aggressive asbestos related disease that is generally considered to be difficult to diagnose, stage and treat. The diagnostic process is continuing to evolve and requires highly skilled pathology input, and generally an extensive list of biomarkers for defi...

Full description

Bibliographic Details
Main Authors: Eric Rozitis, Ben Johnson, Yuen Yee Cheng, Kenneth Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
malignant pleural mesothelioma
CirRNA
DNA methylation
microRNA
epigenetic biomarkers
biomarkers
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01742/full

Similar Items

Similar Items